Literature DB >> 22886924

Enhancement of plasmid DNA immunogenicity with linear polyethylenimine.

Evita V Grant1, Mini Thomas, Jennifer Fortune, Alexander M Klibanov, Norman L Letvin.   

Abstract

The utility of plasmid DNA as an immunogen has been limited by its weak immunogenicity. In the present study, we evaluated the ability of a family of linear polyethylenimine (PEI) polymers, complexed to plasmid DNA, to augment DNA expression in vivo and to enhance antigen-specific adaptive immune responses. We showed that four of five structurally different PEIs that we evaluated increased in vivo DNA expression 20- to 400-fold, and enhanced DNA-induced epitope-specific CD8⁺ T-cell responses 10- to 25-fold in BALB/c and C57BL/6J mice respectively, when delivered intravenously. Functional studies of the PEI-DNA-induced CD8⁺ T-cell responses demonstrated that formulation of DNA with PEI was associated with increased numbers of cells secreting type I cytokines. In addition, PEI-DNA complexes improved antigen-specific T(H) 1-helper cell and humoral responses. Most importantly, the PEI-DNA complexes elicited memory cellular responses, capable of rapid expansion and accelerated clearance of a lethal dose of recombinant Listeria monocytogenes. Lastly, we identified physical properties of PEI-DNA complexes that are associated with enhanced DNA-elicited immunogenicity. These findings demonstrate that PEI polymers can play an important role in the development of DNA-based vaccines in the setting of infectious disease prevention and cancer therapy.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886924     DOI: 10.1002/eji.201242410

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

2.  Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma.

Authors:  A N Meleshko; N A Petrovskaya; N Savelyeva; K P Vashkevich; S N Doronina; N V Sachivko
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

Review 3.  Immune Activities of Polycationic Vectors for Gene Delivery.

Authors:  Xiaotian Zhao; Xiaoming Li; Yi Zhao; Yuan Cheng; Yunqi Yang; Zhiwei Fang; Yangmei Xie; Yao Liu; Yinghui Chen; Yuanming Ouyang; Weien Yuan
Journal:  Front Pharmacol       Date:  2017-08-04       Impact factor: 5.810

Review 4.  Polyethylenimine-based micro/nanoparticles as vaccine adjuvants.

Authors:  Chen Shen; Jun Li; Yi Zhang; Yuce Li; Guanxin Shen; Jintao Zhu; Juan Tao
Journal:  Int J Nanomedicine       Date:  2017-07-31

5.  Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses.

Authors:  Mahboubeh Ebrahimian; Maryam Hashemi; Mohsen Maleki; Gholamreza Hashemitabar; Khalil Abnous; Mohammad Ramezani; Alireza Haghparast
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 6.  Polymeric nanoparticle vaccines to combat emerging and pandemic threats.

Authors:  David Wibowo; Sytze H T Jorritsma; Zennia Jean Gonzaga; Benjamin Evert; Shuxiong Chen; Bernd H A Rehm
Journal:  Biomaterials       Date:  2020-12-10       Impact factor: 12.479

7.  Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy.

Authors:  Jutaek Nam; Sejin Son; Kyung Soo Park; James J Moon
Journal:  Adv Sci (Weinh)       Date:  2021-01-06       Impact factor: 16.806

8.  Engineered biomaterials for development of nucleic acid vaccines.

Authors:  Jun Yang; Yan Li; Shubin Jin; Jing Xu; Paul C Wang; Xing-Jie Liang; Xin Zhang
Journal:  Biomater Res       Date:  2015-02-19

9.  Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Authors:  Yingying Xu; Pak-Wai Yuen; Jenny Ka-Wing Lam
Journal:  Pharmaceutics       Date:  2014-07-10       Impact factor: 6.321

Review 10.  Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung.

Authors:  Leonor de Braganca; G John Ferguson; Jose Luis Santos; Jeremy P Derrick
Journal:  J Immunotoxicol       Date:  2021-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.